| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |